Show simple item record

dc.contributor.authorNaidu, Harinien_US
dc.contributor.authorHuang, Qinen_US
dc.contributor.authorMashimo, Hiroshien_US
dc.date.accessioned2015-07-13T18:47:39Z
dc.date.issued2014en_US
dc.identifier.citationNaidu, Harini, Qin Huang, and Hiroshi Mashimo. 2014. “Gastric antral vascular ectasia: the evolution of therapeutic modalities.” Endoscopy International Open 2 (2): E67-E73. doi:10.1055/s-0034-1365525. http://dx.doi.org/10.1055/s-0034-1365525.en
dc.identifier.issn2364-3722en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:17295741
dc.description.abstractGastric Antral Vascular Ectasia (GAVE) may be an enigmatic source of non-variceal upper GI bleeding associated with various systemic diseases such as connective tissue disorders, liver disease, and chronic renal failure. Successful treatment of GAVE continues to be a challenge and has evolved through the years. Currently, given the rapid response, safety, and efficacy, endoscopic ablative modalities have largely usurped medical treatments as first-line therapy, particularly using argon plasma coagulation. However, other newer ablative modalities such as radiofrequency ablation, cryotherapy, and band ligations are promising. This paper is an overview of GAVE and its various endoscopic and medical therapies.en
dc.language.isoen_USen
dc.publisher© Georg Thieme Verlag KGen
dc.relation.isversionofdoi:10.1055/s-0034-1365525en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423327/pdf/en
dash.licenseLAAen_US
dc.titleGastric antral vascular ectasia: the evolution of therapeutic modalitiesen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalEndoscopy International Openen
dash.depositing.authorHuang, Qinen_US
dc.date.available2015-07-13T18:47:39Z
dc.identifier.doi10.1055/s-0034-1365525*
dash.contributor.affiliatedMashimo, Hiroshi
dash.contributor.affiliatedHuang, Qin


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record